Setup verification and in vivo dosimetry during intraoperative radiation therapy (IORT) for prostate cancer

Antonella Soriani, Valeria Landoni, Simona Marzi, Giuseppe Iaccarino, Biancamaria Saracino, Giorgio Arcangeli, Marcello Benassi

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to check the setup and dose delivered to the patients during intraoperative electron beam radiation therapy (IORT) for prostate cancer. Twenty eight patients underwent IORT after radical prostatectomy for prostate cancer by means of a dedicated mobile accelerator, Novac7 (by Hitesys, SpA, Italy). A 9 MeV electron beam at high dose per pulse was used. Eighteen patients received IORT at escalating doses of 16, 18, and 20 Gy at 85% isodose, six patients for each dose level. Further, ten patients received 20 Gy at 85% isodose. The electron applicator position was checked in all cases by means of two orthogonal images obtained with brilliance intensifier. Target and organ at risk doses were measured in vivo by a MOSFETs dosimetry system. MOSFETs and microMOSFET dosimeters were inserted into sterile catheters and directly positioned into the rectal lumen, for ten patients, and into the bladder to urethra anastomosis, in the last 14 cases. Verification at 0° led to very few adjustments of setup while verifications at 90° often suggested to bring the applicator closer to the target. In vivo dosimetry showed an absorbed dose into the rectum wall ≤1% of the total dose. The average dose value inside the anastomosis, for the 12 patients analyzed, was 23.7 Gy with a standard deviation of ±7.6%, when the prescription was 20 Gy at 85% isodose. Using a C-arm mobile image intensifier, it is possible to assess if the positioning is correct and safe. Radio-opaque clips and liquid were necessary to obtain good visible images. In vivo MOSFETs dosimetry is feasible and reliable. A satisfactory agreement between measured and expected doses was found.

Original languageEnglish
Pages (from-to)3205-3210
Number of pages6
JournalMedical Physics
Volume34
Issue number8
DOIs
Publication statusPublished - 2007

Fingerprint

Prostatic Neoplasms
Radiotherapy
Electrons
Organs at Risk
Urethra
Prostatectomy
In Vivo Dosimetry
Rectum
Surgical Instruments
Italy
Prescriptions
Urinary Bladder
Arm
Catheters

Keywords

  • In vivo dosimetry
  • IORT
  • MOSFET
  • Prostate therapy

ASJC Scopus subject areas

  • Biophysics

Cite this

Setup verification and in vivo dosimetry during intraoperative radiation therapy (IORT) for prostate cancer. / Soriani, Antonella; Landoni, Valeria; Marzi, Simona; Iaccarino, Giuseppe; Saracino, Biancamaria; Arcangeli, Giorgio; Benassi, Marcello.

In: Medical Physics, Vol. 34, No. 8, 2007, p. 3205-3210.

Research output: Contribution to journalArticle

Soriani, Antonella ; Landoni, Valeria ; Marzi, Simona ; Iaccarino, Giuseppe ; Saracino, Biancamaria ; Arcangeli, Giorgio ; Benassi, Marcello. / Setup verification and in vivo dosimetry during intraoperative radiation therapy (IORT) for prostate cancer. In: Medical Physics. 2007 ; Vol. 34, No. 8. pp. 3205-3210.
@article{06071e9106954d9aa33dda4140687719,
title = "Setup verification and in vivo dosimetry during intraoperative radiation therapy (IORT) for prostate cancer",
abstract = "The purpose of this study was to check the setup and dose delivered to the patients during intraoperative electron beam radiation therapy (IORT) for prostate cancer. Twenty eight patients underwent IORT after radical prostatectomy for prostate cancer by means of a dedicated mobile accelerator, Novac7 (by Hitesys, SpA, Italy). A 9 MeV electron beam at high dose per pulse was used. Eighteen patients received IORT at escalating doses of 16, 18, and 20 Gy at 85{\%} isodose, six patients for each dose level. Further, ten patients received 20 Gy at 85{\%} isodose. The electron applicator position was checked in all cases by means of two orthogonal images obtained with brilliance intensifier. Target and organ at risk doses were measured in vivo by a MOSFETs dosimetry system. MOSFETs and microMOSFET dosimeters were inserted into sterile catheters and directly positioned into the rectal lumen, for ten patients, and into the bladder to urethra anastomosis, in the last 14 cases. Verification at 0° led to very few adjustments of setup while verifications at 90° often suggested to bring the applicator closer to the target. In vivo dosimetry showed an absorbed dose into the rectum wall ≤1{\%} of the total dose. The average dose value inside the anastomosis, for the 12 patients analyzed, was 23.7 Gy with a standard deviation of ±7.6{\%}, when the prescription was 20 Gy at 85{\%} isodose. Using a C-arm mobile image intensifier, it is possible to assess if the positioning is correct and safe. Radio-opaque clips and liquid were necessary to obtain good visible images. In vivo MOSFETs dosimetry is feasible and reliable. A satisfactory agreement between measured and expected doses was found.",
keywords = "In vivo dosimetry, IORT, MOSFET, Prostate therapy",
author = "Antonella Soriani and Valeria Landoni and Simona Marzi and Giuseppe Iaccarino and Biancamaria Saracino and Giorgio Arcangeli and Marcello Benassi",
year = "2007",
doi = "10.1118/1.2750965",
language = "English",
volume = "34",
pages = "3205--3210",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Setup verification and in vivo dosimetry during intraoperative radiation therapy (IORT) for prostate cancer

AU - Soriani, Antonella

AU - Landoni, Valeria

AU - Marzi, Simona

AU - Iaccarino, Giuseppe

AU - Saracino, Biancamaria

AU - Arcangeli, Giorgio

AU - Benassi, Marcello

PY - 2007

Y1 - 2007

N2 - The purpose of this study was to check the setup and dose delivered to the patients during intraoperative electron beam radiation therapy (IORT) for prostate cancer. Twenty eight patients underwent IORT after radical prostatectomy for prostate cancer by means of a dedicated mobile accelerator, Novac7 (by Hitesys, SpA, Italy). A 9 MeV electron beam at high dose per pulse was used. Eighteen patients received IORT at escalating doses of 16, 18, and 20 Gy at 85% isodose, six patients for each dose level. Further, ten patients received 20 Gy at 85% isodose. The electron applicator position was checked in all cases by means of two orthogonal images obtained with brilliance intensifier. Target and organ at risk doses were measured in vivo by a MOSFETs dosimetry system. MOSFETs and microMOSFET dosimeters were inserted into sterile catheters and directly positioned into the rectal lumen, for ten patients, and into the bladder to urethra anastomosis, in the last 14 cases. Verification at 0° led to very few adjustments of setup while verifications at 90° often suggested to bring the applicator closer to the target. In vivo dosimetry showed an absorbed dose into the rectum wall ≤1% of the total dose. The average dose value inside the anastomosis, for the 12 patients analyzed, was 23.7 Gy with a standard deviation of ±7.6%, when the prescription was 20 Gy at 85% isodose. Using a C-arm mobile image intensifier, it is possible to assess if the positioning is correct and safe. Radio-opaque clips and liquid were necessary to obtain good visible images. In vivo MOSFETs dosimetry is feasible and reliable. A satisfactory agreement between measured and expected doses was found.

AB - The purpose of this study was to check the setup and dose delivered to the patients during intraoperative electron beam radiation therapy (IORT) for prostate cancer. Twenty eight patients underwent IORT after radical prostatectomy for prostate cancer by means of a dedicated mobile accelerator, Novac7 (by Hitesys, SpA, Italy). A 9 MeV electron beam at high dose per pulse was used. Eighteen patients received IORT at escalating doses of 16, 18, and 20 Gy at 85% isodose, six patients for each dose level. Further, ten patients received 20 Gy at 85% isodose. The electron applicator position was checked in all cases by means of two orthogonal images obtained with brilliance intensifier. Target and organ at risk doses were measured in vivo by a MOSFETs dosimetry system. MOSFETs and microMOSFET dosimeters were inserted into sterile catheters and directly positioned into the rectal lumen, for ten patients, and into the bladder to urethra anastomosis, in the last 14 cases. Verification at 0° led to very few adjustments of setup while verifications at 90° often suggested to bring the applicator closer to the target. In vivo dosimetry showed an absorbed dose into the rectum wall ≤1% of the total dose. The average dose value inside the anastomosis, for the 12 patients analyzed, was 23.7 Gy with a standard deviation of ±7.6%, when the prescription was 20 Gy at 85% isodose. Using a C-arm mobile image intensifier, it is possible to assess if the positioning is correct and safe. Radio-opaque clips and liquid were necessary to obtain good visible images. In vivo MOSFETs dosimetry is feasible and reliable. A satisfactory agreement between measured and expected doses was found.

KW - In vivo dosimetry

KW - IORT

KW - MOSFET

KW - Prostate therapy

UR - http://www.scopus.com/inward/record.url?scp=34547489629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547489629&partnerID=8YFLogxK

U2 - 10.1118/1.2750965

DO - 10.1118/1.2750965

M3 - Article

C2 - 17879783

AN - SCOPUS:34547489629

VL - 34

SP - 3205

EP - 3210

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 8

ER -